Transport Pharmaceuticals’ Device/Drug Combo For Herpes To Launch In 2007
This article was originally published in The Pink Sheet Daily
Executive Summary
Pivotal, Phase III U.S. trial for iontophoresis drug delivery device is expected to begin in late 2005. The combo product’s drug ingredient is acyclovir, and FDA’s drug center will take the lead on pre-market review, Transport says.